Drug Cos. To Pay $49M For State-Led Generic Pricing Claims

By Matthew Perlman · October 31, 2024, 9:27 PM EDT

A contingent of state-level enforcers reached settlements totaling $49.1 million on Thursday with Heritage Pharmaceuticals Inc. and Apotex Corp. for their alleged part in a wide-ranging conspiracy to inflate the price...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Case Information

Case Title

Connecticut et al v. Aurobindo Pharma USA, Inc. et al

Case Number

Court

Connecticut

Nature of Suit

Anti-Trust

Date Filed

December 15, 2016

Case Title

Connecticut et al v. Teva Pharmaceuticals USA, Inc.

Case Number

Court

Connecticut

Nature of Suit

Anti-Trust

Date Filed

May 10, 2019

Case Title

Connecticut et al v. Sandoz, Inc. et al

Case Number

Court

Connecticut

Nature of Suit

Anti-Trust

Date Filed

June 10, 2020

Recent Articles By Matthew

November 21, 2024
Nurse Staffing Exec Can't Trim Fraud Charge In Antitrust Case
November 20, 2024
PBMs Sue To Block FTC's In-House Insulin Pricing Case
November 07, 2024
Teva Can't End Inhaler Antitrust Suit But Gets Claim Nixed
November 01, 2024
Health Data Co. Urges 4th Circ. To Keep Access Open
October 30, 2024
Ohio PBM Case Will Wait For High Court Ruling
October 24, 2024
PBMs Want Separate FTC Hearings Over Insulin Prices
October 21, 2024
NC Justices Revive Challenge To Hospital Competition Law
October 15, 2024
FTC Wants More Info On $1.36B Home Healthcare Deal
October 07, 2024
Justices Won't Hear Shkreli's Bid To Undo $64M Disgorgement
September 23, 2024
Medical Records Co. Accused Of Blocking Data Access